The time has finally come – the registration for Pitchbühel 2.0 opens today! 🔊 After we got incredible feedback from our founders last year and ended up investing in one of the founders who pitched us their company for the first time in the gondola (not announced yet), we decided Pitchbühel must become a yearly tradition. So we will follow the same procedure as last year: only one week after the legendary Streif Hahnenkamm race where the world meets in Kitzbühel to celebrate the heroes of skiing, we are looking for the next heroes in health tech. We are inviting 20 digital health founders to join us for an unforgettable day trip to Kitzbühel which could be their ticket to raising their round with us. While sitting with the YZR Capital team in the Hahnenkamm gondola, surrounded by breathtaking views of the alps, you will have the opportunity to pitch your company. Before and after pitching, there will be plenty of time to hit the slopes together, followed by joint drinks and food. In short, the main facts: ⏱️ January 30th 📍 Kitzbühel – meeting point is Munich, we will take care of your transport ⛷️ Pitching, skiing, drinking, networking If you’re a health tech founder and would like to participate in the event, please fill out our application form by November 15th. Link in 1st comment! We can’t wait! 🏂 #healthtech #startups #event
YZR Capital
Wagniskapital- und Private-Equity-Auftraggeber
Munich, Bavaria 3.093 Follower:innen
Health Tech Venture Capital Fund
Info
YZR is a long-term oriented investment company based in Munich, which focuses on the added value of synergistic expertise in the investment team and sector focus. For this purpose, YZR combines a professional investor culture with entrepreneurial experience and profound sector know-how. With the newly launched Fund I, YZR supports European health tech founders on their way to becoming global technology leaders and aims to contribute to strengthening the European health tech ecosystem.
- Website
-
http://www.yzr.vc
Externer Link zu YZR Capital
- Branche
- Wagniskapital- und Private-Equity-Auftraggeber
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Munich, Bavaria
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2021
- Spezialgebiete
- Venture Capital, Health Tech und Early Stage
Orte
-
Primär
Maria-Theresia Straße
Munich, Bavaria 81675, DE
Beschäftigte von YZR Capital
Updates
-
Welcome to our portfolio, Univa! 👋 UK-based Univa is revolutionizing eating disorder care with a novel personalized digital platform. We’re excited to share that we have led the £1m pre-seed round, with participation from Calm/Storm. Over the past five years, hospital admissions for eating disorders have surged by 84% in the UK. The lack of personalization in treatments, combined with a shortage of skilled clinicians, results in half of those with eating disorders not responding to treatment. Despite the need for early intervention, the NHS is only able to provide care for 10% of adults with eating disorders. Richard Andrews, Co-Founder & CEO at Univa comments: “Our goal is to revolutionise care pathways, providing tools that empower clinicians and deliver meaningful results. We aim to keep people out of hospital and enable better long-term recovery while saving costs for the healthcare system. Univa’s platform will augment the overwhelmed clinical workforce by providing evidence-based tools to reach more patients and families, enabling earlier intervention, improving monitoring, and faster recovery.” We’re happy to back two experienced healthcare founders on this mission – looking forward to our journey together Richard Andrews and Jose Santos! 💥 #healthcare #venturecapital
-
We had a blast with top #HealthTech founders and investors at the *HealthTech x Google* event last week in Berlin! 🚀 The energy was incredible, and if you want to know where the future of healthcare investment is headed, this is the event to keep on your radar. 💡 We had the privilege of co-hosting this event alongside Google & Revent as well as Creandum, Lightrock, General Catalyst, Speedinvest, Amino Collective, Sofinnova Partners, and Heal Capital. Together, we brought some of the most innovative founders and cutting-edge investors in European healthcare to the table. 🩺 The event also featured roundtable discussions with deep dives into emerging trends. 💡 Key takeaways from the roundtable by our founding partner Reinhard Meier, MD MBA, on LLMs in healthcare: We discussed the primary and secondary benefits of LLMs in healthcare, as well as use cases such as medical documentation automation, patient record aggregation, clinical trial matching, virtual health assistants, symptom checkers, clinical decision support and treatment recommendations, personalised patient communications, claims automation, scheduling and workflow optimization, drug discovery and development, and last but not least, mental health support as our portfolio company clare&me. Huge thanks to Franca Pullem and Otto Birnbaum for the great organization! 👏 Thanks to co-hosts and attendees: Javier Nunez-Vicandi Alexandre Momeni Andrea Zitna Hendrik Steenfadt, MD Hannah Looks Manuel Grossmann, Tim Schneider, Dr. Sievert Weiss, Dr. Laura Seifert, Luisa Wasilewski, Edward Kliphuis, Martin Karschkes, Beata Klein, Amelia Zins, Christopher Steinau, Nicolas Weber, Peter Schlecht & many more. #healthtech #venturecapital
-
Welcome to the YZR team, Till Quitzau! 👋 We are thrilled to welcome Till Quitzau as our new Investment Analyst at YZR Capital! With experience from Bain & Company and internships at redalpine, Bank of America, and PlusDental, Till will make valuable contributions to our investment team. Till holds a Master’s in International Management from Esade and a Bachelor’s in Business Administration from the University of Mannheim. In his free time, you will most likely find him at a tennis court or football field or following his love for good music. Till Quitzau, we are happy to have you on board! ☀ #venturecapital #healthtech
-
Happy to announce that our portfolio company clare&me has secured €3.7m in total funding to develop the first Clincial Large Language Model! 👏 The funding came from YZR as a lead investor, with participation from Kodori Ventures, Material Ventures, and Antler, including also grant funding from the IBB and European Union. With the new funds, the company will accelerate its tech development, and start partnerships with clinics. 🚀 We are super proud to have been backing Emilia Theye and Celina Messner since their starting days in 2021. It has been amazing to be part of your journey, and we can't wait for the next years together! If you would like to know more about clare&me, please find the link to the Handelsblatt article in the first comment. #healthtech #venturecapital
-
YZR is growing, so we moved! 🚀 Last week we hosted our office opening reception in Maria-Theresia-Straße in Munich. In the last two years, not only our portfolio grew significantly, but also our team. Hence, it was time for a larger office. With more than 60 fellow investors, portfolio founders, and YZR friends we inaugurated our office - with a not so successful but very fun "Fassanstich", and private Rikscha rides. Thank you everyone for coming, it was a blast! 🙏 #healthtech #venturecapital
-
+1
-
Welcome to our portfolio, Esper Bionics ! 🦾 Esper Bionics is a pioneering US-based engineering company that develops the first bionic ecosystem in the world. It’s flagship product, the Esper Hand, made it on the cover of TIME magazine as one of the Best Innovations of 2022. We’re excited to share that we led the $5m round, which was joined by EBRD and u.ventures. The Esper Hand is perfect for comfortable use as a lifestyle device, with uniquely designed muscle sensors, providing users with better control compared to other prosthetics. Unlike most robotic arms that rely on just two sensors for all hand functions, the Esper Hand uses ~ 20 sensors with a cloud-based software platform that is housing its AI control algorithms built around it. However, Esper is not a prosthetic limb company: their vision is to develop next-generation sensors for widespread use, which will be licensed to other wearable manufacturers. Dima Gazda, Co-Founder & CEO at Esper Bionics states: "Our users are our inspiration to innovate and excel. We have received exceptional feedback from them, and we are committed to making the Esper Hand even more dexterous, ensuring it reaches everyone in need. By enhancing manufacturing, developing new types of sensors, and helping more people, we are getting closer to pushing the boundaries of human potential." Congrats Dima Gazda, Anna Believantseva, Ihor Ilchenko, Kyrylo Perevozchykov, and their team! We are very happy to be on board! 👏 Read more about Esper on Sifted, link in 1st comment. #healthtech #bionics
-
Meet us in Paris! 👋 Our Founding Partner, Markus Feuerecker, will be at the Goldman Sachs French Disruptive Technology Symposium in Paris on the 26th of June. If you're in town and keen to discuss the health tech industry or learn about YZR Capital, please reach out! #healthtech #venturecapital
-
Meet us in London! 👋 Our Founding Partner, Markus Feuerecker, will be at the J.P. Morgan European Healthcare Symposium in London on the 20th of June. If you're in town and keen to discuss the health tech industry or learn about YZR Capital, please reach out! #healthtech #venturecapital
-
Meet us at HLTH Europe conference! 👋 Reinhard Meier, MD MBA and Paul Epple will be at HLTH Europe 2024 in Amsterdam next week. Feel free to shoot us a message if you're around, or meet us at our panel! 💰 Sales: Reclaiming healthcare's dirtiest word 📅 18.06.24, 10:40 - 11:20 at the Startup Stage Looking forward to join you on the panel Tim Juergens | Marius Mainz | Jamie Lu | Maximilian Greschke #hlth #hltheurope #healthtech